Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Inherit Metab Dis ; 36(2): 293-307, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23371450

RESUMO

Mucopolysaccharidosis IVA (MPS IVA; Morquio A syndrome) is an autosomal recessive lysosomal storage disorder resulting from a deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS) activity. Diagnosis can be challenging and requires agreement of clinical, radiographic, and laboratory findings. A group of biochemical genetics laboratory directors and clinicians involved in the diagnosis of MPS IVA, convened by BioMarin Pharmaceutical Inc., met to develop recommendations for diagnosis. The following conclusions were reached. Due to the wide variation and subtleties of radiographic findings, imaging of multiple body regions is recommended. Urinary glycosaminoglycan analysis is particularly problematic for MPS IVA and it is strongly recommended to proceed to enzyme activity testing even if urine appears normal when there is clinical suspicion of MPS IVA. Enzyme activity testing of GALNS is essential in diagnosing MPS IVA. Additional analyses to confirm sample integrity and rule out MPS IVB, multiple sulfatase deficiency, and mucolipidoses types II/III are critical as part of enzyme activity testing. Leukocytes or cultured dermal fibroblasts are strongly recommended for enzyme activity testing to confirm screening results. Molecular testing may also be used to confirm the diagnosis in many patients. However, two known or probable causative mutations may not be identified in all cases of MPS IVA. A diagnostic testing algorithm is presented which attempts to streamline this complex testing process.


Assuntos
Glicosaminoglicanos/urina , Mucopolissacaridose IV/diagnóstico , Mucopolissacaridose IV/enzimologia , Algoritmos , Fibroblastos/enzimologia , Humanos , Leucócitos/enzimologia , Mucolipidoses/diagnóstico , Mucopolissacaridose IV/genética , Mucopolissacaridose IV/urina , Doença da Deficiência de Múltiplas Sulfatases/diagnóstico , Mutação , Patologia Molecular/métodos
2.
Bioconjug Chem ; 23(3): 557-64, 2012 Mar 21.
Artigo em Inglês | MEDLINE | ID: mdl-22372747

RESUMO

The clinical phenotype of Sanfilippo Syndrome is caused by one of four enzyme deficiencies that are associated with a defect in mucopolysaccharide metabolism. The four subtypes (A, B, C, and D) are each caused by an enzyme deficiency involved in the degradation of heparan sulfate. We have developed a highly efficient synthesis of the substrates and internal standards required for the enzymatic assay of each of the four enzymes. The synthesis of the substrates involves chemical modification of a common intermediate. The substrates and internal standards allow the measurement of the enzymes relevant to heparan N-sulfatase (type A); N-acetyl-α-glucosaminidase (type B); acetyl-CoA:α-glucosamide N-acetyltransferase (type C); and N-acetylglucosamine 6-sulfatase (type D). The internal standards are similar to the substrates and allow for the accurate quantification of the enzyme assays using tandem mass spectrometry. The synthetic substrates incorporate a coumarin moiety and can also be used in fluorometric enzyme assays. We confirm that all four substrates can detect the appropriate Sanfilippo Syndrome in fibroblast lysates, and the measured enzyme activities are distinctly lower by a factor of 10 when compared to fibroblast lysates from unaffected persons.


Assuntos
Mucopolissacaridose III/diagnóstico , Espectrometria de Massas em Tandem/métodos , Humanos , Padrões de Referência , Especificidade por Substrato
3.
Ann Neurol ; 65(6): 753-7, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19557856

RESUMO

We performed high-resolution in vitro proton nuclear magnetic resonance spectroscopy on cerebrospinal fluid and urine samples of 44 patients with leukodystrophies of unknown cause. Free sialic acid concentration was increased in cerebrospinal fluid of two siblings with mental retardation and mild hypomyelination. By contrast, urinary excretion of free sialic acid in urine was normal on repeated testing by two independent methods. Both patients were homozygous for the K136E mutation in SLC17A5, the gene responsible for the free sialic acid storage diseases. Our findings demonstrate that mutations in the SLC17A5 gene have to be considered in patients with hypomyelination, even in the absence of sialuria.


Assuntos
Ácido N-Acetilneuramínico/líquido cefalorraquidiano , Transportadores de Ânions Orgânicos/genética , Doença do Armazenamento de Ácido Siálico/genética , Simportadores/genética , Adolescente , Criança , Diagnóstico Diferencial , Doenças Desmielinizantes Hereditárias do Sistema Nervoso Central/líquido cefalorraquidiano , Doenças Desmielinizantes Hereditárias do Sistema Nervoso Central/diagnóstico , Doenças Desmielinizantes Hereditárias do Sistema Nervoso Central/genética , Doenças Desmielinizantes Hereditárias do Sistema Nervoso Central/urina , Humanos , Ácido N-Acetilneuramínico/genética , Ácido N-Acetilneuramínico/urina , Ressonância Magnética Nuclear Biomolecular/métodos , Doença do Armazenamento de Ácido Siálico/líquido cefalorraquidiano , Doença do Armazenamento de Ácido Siálico/diagnóstico , Doença do Armazenamento de Ácido Siálico/urina , Adulto Jovem
5.
Genet Med ; 4(6): 420-6, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12509712

RESUMO

PURPOSE: Mucopolysaccharidosis type I (MPS I) is an autosomal recessive disorder resulting from a deficiency of the lysosomal glycosidase, alpha-L-iduronidase (IDUA). Patients with MPS I present with variable clinical manifestations ranging from severe to mild. To facilitate studies of phenotype-genotype correlation, the authors performed molecular studies to detect mutations in MPS I patients and characterize single nucleotide polymorphism (SNP) in the gene. METHODS: Twenty-two unrelated MPS I patients were subjects for mutation detection using reverse transcriptional polymerase chain reaction (RT-PCR) and genomic PCR sequencing. Polymorphism analyses were performed on controls by restriction enzyme assays of PCR amplicons flanking nine intragenic single nucleotide polymorphic alleles. RESULTS: Eleven different mutations including two common mutations (Q70X, W402X), five recurrent mutations (D315Y, P533R, R621X, R628X, S633L), and four novel mutations (R162I, G208D, 1352delG, 1952del25bp) were identified from MPS I patients. Multiple SNP alleles coexisting with the disease-causing mutations were detected. Allelic frequencies for nine SNP alleles including A8, A20, Q33H, L118, N181, A314, A361T, T388, and T410 were determined. CONCLUSIONS: The results provide further evidence for the mutational heterogeneity among MPS I patients and point out possible common haplotype structures in the gene.


Assuntos
Iduronidase/genética , Mucopolissacaridose I/genética , Mutação , Polimorfismo de Nucleotídeo Único , População Negra , Feminino , Frequência do Gene , Heterogeneidade Genética , Variação Genética , Haplótipos , Humanos , Masculino , Mucopolissacaridose I/enzimologia , População Branca
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...